$507.08−$29.12 (-5.43%)as of market close, Aug 13, 2026
☾ After hours:$507.37+0.00%3:59 PM ET
MDGL — Madrigal Pharmaceuticals Inc. stock price, chart and key statistics
Key stats#
Price data
- Price
- $507.08
- Change YTD
- -12.92%
- Market cap
- 11.7B
- Enterprise value
- 10.9B
- Shares outstanding
- 23.1M
- 52W low
- $351.32
- 52W high
- $615.00
- From 52W high
- -17.55%
- From 52W low
- +44.34%
- 52W range
- 59%
- Beta
- -0.97
Volume
- Rel volume
- 0.68×
- 30D volume
- 359.8K
- 30D $ vol
- 188.1M
Fundamentals
- Sales (ttm)
- 1.3B
- Sales/share
- $55.57
- EPS (ttm)
- -$11.26
- FCF (ttm)
- -206.3M
- FCF/share
- $-8.93
- Book value/share
- $22.67
- Net margin
- -25.32%
- ROE
- -62.07%
- ROA
- -26.12%
- Debt / equity
- 0.65×
- Current ratio
- 3.20
Growth (CAGR, ttm) · 10Y
- Sales
- n/a
- Net income
- n/a
- FCF
- n/a
- Shares
- +19.36%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- n/a
- Sales/share
- n/a
- FCF/share
- n/a
- Book value/share
- +7.94%
- Price
- +52.34%
- Total return
- +52.34%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- Fwd P/E
- 53.1×
- 9.1×
- 22.4×
- EV/Sales (ttm)
- 8.5×
- -1.76%
- -3.66%
- -3.66%
- 0.00%
- 0.00%
Vs own 10Y history
- P/S
- 0th
- P/B
- 86th
Bar = where today's multiple sits in MDGL's own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return#
1D
-5.43%
1W
-0.64%
1M
-7.85%
3M
-2.27%
YTD
-12.92%
1Y
+41.25%
5Y
+470.91%
Financial statements
Open full MDGL financials →Related Health Care#
1MMadrigal Pharmaceuticals Inc. (MDGL) trades at $507.08 with a live price and an interactive chart covering 19+ years of daily price history, plus key valuation metrics. ChartRow also publishes MDGL's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full MDGL financial statements →